Full Text View
Tabular View
No Study Results Posted
Related Studies
DaunoXome + Ara-C vs Daunorubicin + Ara-C in Elderly AML
This study has been completed.
Study NCT00589082   Information provided by Gruppo Italiano Malattie EMatologiche dell'Adulto
First Received: December 24, 2007   Last Updated: January 8, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
AML
Elderly
Interventions listed in this trial
DaunoXome
Daunorubicine
Additional drug interventions recognized in this trial
Daunorubicin
More general drug interventions related to this trial
Antibiotics, Antineoplastic
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Gruppo Italiano Malattie EMatologiche dell'Adulto


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services